Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase EARLY_PHASE1 2Phase 1 2Phase 2 1Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2

Conditions

Colorectal Neoplasms 8Glioma 7Breast Neoplasms 7Neoplasms 6Glioblastoma 6Pancreatic Neoplasms 5Neoplasm Metastasis 5Recurrence 4Lymphoma, B-Cell 4Lymphoma 4Brain Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Multiple Myeloma 3Melanoma 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Sarcoma 2Pancreatic Ductal Adenocarcinoma 2Myelodysplastic Syndromes 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoglobulin Light-chain Amyloidosis 2Carcinoma, Transitional Cell 2Carcinoma, Squamous Cell 2Carcinoma, Hepatocellular 2Burkitt Lymphoma 2Advanced Solid Tumors 2Uterine Cervical Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Immunoglobulin Light-chain Amyloidosis × 30 days × Clear all
NCT07626476 2026-06-04

Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis

Beijing Boren Hospital

Phase EARLY_PHASE1 Recruiting
30 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis, Recurrence

NCT07615270 2026-05-29

A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement

Stanford University

Phase EARLY_PHASE1 Not yet recruiting
5 enrolled
Plasma cell

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡